# SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry

> **NCT05880680** · — · RECRUITING · sponsor: **Galaxy Therapeutics INC** · enrollment: 200 (estimated)

## Conditions studied

- Aneurysm
- Aneurysm, Ruptured

## Interventions

- **DEVICE:** SEAL Device

## Key facts

- **NCT ID:** NCT05880680
- **Lead sponsor:** Galaxy Therapeutics INC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-09
- **Primary completion:** 2026-12-31
- **Final completion:** 2030-06-15
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05880680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05880680, "SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05880680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*